Eikon Therapeutics, Inc.
EIKN
$10.73
$0.020.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -88.41M | -82.96M | -79.66M | -105.21M | |
| Total Depreciation and Amortization | 5.13M | 5.21M | 5.11M | 6.31M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3.76M | 1.85M | 3.21M | 26.18M | |
| Change in Net Operating Assets | 14.56M | -13.91M | 29.62M | 39.99M | |
| Cash from Operations | -64.96M | -89.80M | -41.72M | -32.74M | |
| Capital Expenditure | -251.00K | -262.00K | -66.00K | -21.72M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 46.68M | -202.96M | 40.78M | -14.16M | |
| Cash from Investing | 46.43M | -203.22M | 40.71M | -35.88M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 25.00K | 349.31M | 1.09M | 529.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | 0.00 | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -10.00K | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 25.00K | 349.31M | 1.09M | 519.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -18.50M | 56.29M | 75.00K | -68.09M | |